when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

August 14, 2025OTULFIupdated 5mo ago

community read0 votes

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalJan 15, 2026 · 264d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalAug 14, 2025 · 418d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 30, 2025 · 524d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 30, 2025 · 524d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalApr 14, 2025 · 540d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalMar 21, 2025 · 564d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalFeb 19, 2025 · 594d ago
approvalOTULFI (USTEKINUMAB-AAUZ) — FDA approvalSep 27, 2024 · 739d ago

same company · ±60 days · 4

approvalOTULFI: OTULFI (USTEKINUMAB-AAUZ) — FDA approvalAug 14, 2025
device recallFresenius Kabi USA, LLC device recall (Cls II)Sep 3, 2025
approvalCAFFEINE CITRATE: CAFFEINE CITRATE — FDA approvalSep 26, 2025
approvalIFOSFAMIDE: IFOSFAMIDE — FDA approvalSep 29, 2025

🐶 often sniffed alongside

top 5

tagApproval36 co-mentions · 9 sources
drugRNS-6018 co-mentions · 9 sources
companyFresenius Kabi USA LLC18 co-mentions · 9 sources
drugustekinumab18 co-mentions · 9 sources
drugSTELARA18 co-mentions · 9 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?